Fentanyl Transdermal System Recall Lawsuit

Tweet

Fentanyl Transdermal System: Recall – Potential for Active Ingredient to Release Faster Than Specified

October 22, 2010 – This week, the FDA notified healthcare professionals and patients that laboratory testing identified a patch that released its active ingredient faster than the approved specification. An accelerated release of Fentanyl can lead to adverse events for at-risk patients including (but not limited to):

• excessive sedation
• respiratory depression
• hypoventilation (slow breathing)
• apnea (temporary suspension of breathing)

What are Fentanyl Patches used to Treat?

The Fentanyl Transdermal System is indicated for the management of persistent, moderate to severe chronic pain that requires continuous, around-the-clock opioid administration for an extended period of time and cannot be managed by other means such as non-steroidal analgesics, opioid combination products, or immediate release opioids. The product is manufactured for Actavis by Corium International in the United States.

Do I have a Fentanyl Transdermal System Recall Injury Accident Lawsuit?

The Defective Drug & Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in faulty Fentanyl pain patch overdose & injury lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.

Free Fentanyl Patch Recall Case Evaluation: If you or a loved one has been injured by a defective Fentanyl pain patch included in this recall, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.